What the buyer wrote
TB Research Group, National Infection Service, Public Health England (PHE) awarded a contract for the provision of iQue screening platform merging high throughput screening with high content flow cytometry to IntelliCyt Corporation. This purchase is to support the screening of antimicrobial activity on current and novel drugs against Mycobacterium tuberculosis. The iQue Plus Screener is the only instrument on the market capable of the speeds required for this work, as it can analyse samples from a full 96-well plate in
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- Provision of iQue Screening Platform
- How they are buying
- Given to one supplier, no competitionNobody else was asked, and the buyer has to be able to justify that.
- Type
- goods
- Suitable for small firms
- The buyer says yes. What that is worth
- Work starts
- 16 Feb 2017
- Work ends
- 15 Feb 2022
Who the buyer named
The buyer published a contact address on this notice.